Around three million people live in the Republic of Armenia, which sits between Georgia, Azerbaijan, Iran and Turkey. The country became independent with the dissolution of the Soviet Union in 1991.

Médecins Sans Frontières/Doctors Without Borders (MSF) first worked in the country in 1988, when we responded to a devastating earthquake. Later we started a programme for children in difficult situations, including those living on the streets.

Tuberculosis (TB) remains a major public health issue in Armenia, with high rates of the drug-resistant form of the disease. Standard treatments for drug-resistant TB are long and toxic. However, Armenia was one of the first countries in the world to authorise the use of two new drugs for the treatment of MDR-TB: bedaquiline and delamanid, which promise to be less toxic and more effective.